Oelze, M., Kröller-Schön, S., Welschof, P., Jansen, T., Hausding, M., Mikhed, Y., . . . Daiber, A. (2014). The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity. PLoS One.
Citação norma ChicagoOelze, Matthias, et al. "The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model By Interfering With Oxidative Stress and Glucotoxicity." PLoS One 2014.
Citação norma MLAOelze, Matthias, et al. "The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model By Interfering With Oxidative Stress and Glucotoxicity." PLoS One 2014.